As of 2025-01-21, the Relative Valuation of Alexion Pharmaceuticals Inc (ALXN) is 86.28 USD. This relative valuation is based on P/E multiples. With the latest stock price at 182.50 USD, the upside of Alexion Pharmaceuticals Inc based on Relative Valuation is -52.7%.
The range of the Relative Valuation is 63.29 - 117.96 USD.
| Range | Selected | |
| Trailing P/E multiples | 22.6x - 31.8x | 26.6x |
| Forward P/E multiples | 24.4x - 45.4x | 34.9x |
| Fair Price | 63.29 - 117.96 | 86.28 |
| Upside | -65.3% - -35.4% | -52.7% |
| Date | P/E |